Recruiting Alopecia Studies in Minneapolis
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
The purpose of the study is to see if Clascoterone can help people with male pattern hair loss to recovery and see if the treatment is effective and safe and how well the drug is tolerated by subjects...
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
The main purpose of this study is to measure the efficacy of farudodstat compared to placebo at Week 12 from the treatment start, in adult participants with Alopecia Areata (AA) with 30% or greater sc...
About Alopecia Clinical Trials in Minneapolis
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
There are currently 2 alopecia clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 786 participants. Research is being sponsored by Cassiopea SpA, ASLAN Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alopecia Clinical Trials in Minneapolis — FAQ
Are there alopecia clinical trials in Minneapolis?
Yes, there are 2 alopecia clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What alopecia treatments are being tested?
The 2 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for alopecia.
Data updated March 2, 2026 from ClinicalTrials.gov